Cargando…

Exosomes as a New Delivery Vehicle in Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) is a type of chronic relapsing inflammatory disease. The pathogenesis of IBD is still unclear, which may involve environmental factors, genetic factors, intestinal microbiota disorder, and abnormal immune responses. Exosomes (30–150 nm) are found in various body flui...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiaomei, Zhou, Guoliang, Zhou, Wanwan, Wang, Xin, Wang, Xiao, Miao, Chenggui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539337/ https://www.ncbi.nlm.nih.gov/pubmed/34683937 http://dx.doi.org/10.3390/pharmaceutics13101644

Ejemplares similares

The Research Progress of Exosomes in Osteoarthritis, With Particular Emphasis on the Mediating Roles of miRNAs and lncRNAs
por: Miao, Chenggui, et al.
Publicado: (2021)

Exosome as a Delivery Vehicle for Cancer Therapy
por: Moon, Bohyun, et al.
Publicado: (2022)

Exosomes as New Generation Vehicles for Drug Delivery: Biomedical Applications and Future Perspectives
por: Rajput, Amarjitsing, et al.
Publicado: (2022)

Exosomes as an Emerging Plasmid Delivery Vehicle for Gene Therapy
por: Wallen, Margaret, et al.
Publicado: (2023)

Therapeutic potential of exosome‐based personalized delivery platform in chronic inflammatory diseases
por: Wang, Chenglong, et al.
Publicado: (2023)

Exosome-Induced Regulation in Inflammatory Bowel Disease
por: Zhang, Huiting, et al.
Publicado: (2019)

Exosomes as therapeutic vehicles in liver diseases
por: Ding, Jingyi, et al.
Publicado: (2021)

Novel drug delivery systems of Chinese medicine for the treatment of inflammatory bowel disease
por: Gao, Caifang, et al.
Publicado: (2019)

Exosomes as smart drug delivery vehicles for cancer immunotherapy
por: Zhang, Huan, et al.
Publicado: (2023)

An oral delivery vehicle based on konjac glucomannan acetate targeting the colon for inflammatory bowel disease therapy
por: Wang, Chuang, et al.
Publicado: (2022)

Current Status and Prospect of Delivery Vehicle Based on Mesenchymal Stem Cell-Derived Exosomes in Liver Diseases
por: Lu, Xinfeng, et al.
Publicado: (2023)

Plant-Derived Exosomes as a Drug-Delivery Approach for the Treatment of Inflammatory Bowel Disease and Colitis-Associated Cancer
por: Cai, Ying, et al.
Publicado: (2022)

RNA Methylations in Cardiovascular Diseases, Molecular Structure, Biological Functions and Regulatory Roles in Cardiovascular Diseases
por: Zhou, Wanwan, et al.
Publicado: (2021)

Exosomes as Naturally Occurring Vehicles for Delivery of Biopharmaceuticals: Insights from Drug Delivery to Clinical Perspectives
por: Butreddy, Arun, et al.
Publicado: (2021)

Exosome‐mediated effects and applications in inflammatory bowel disease
por: Ocansey, Dickson K. W., et al.
Publicado: (2020)

Emerging Role of Exosomes in Diagnosis and Treatment of Infectious and Inflammatory Bowel Diseases
por: Larabi, Anaïs, et al.
Publicado: (2020)

Are exosomes the vehicle for protein aggregate propagation in neurodegenerative diseases?
por: Lim, Yoon-Ju, et al.
Publicado: (2017)

Mesenchymal Stem Cell-derived Exosomes: Novel Therapeutic Approach for Inflammatory Bowel Diseases
por: Tian, Cheng-mei, et al.
Publicado: (2023)

New Insights of Oral Colonic Drug Delivery Systems for Inflammatory Bowel Disease Therapy
por: Teruel, Adrian H., et al.
Publicado: (2020)

Mesenchymal Stem Cells-Derived Exosomes as Dexamethasone Delivery Vehicles for Autoimmune Hepatitis Therapy
por: Zhao, Jiawei, et al.
Publicado: (2021)

Plant-derived exosomal nanoparticles: potential therapeutic for inflammatory bowel disease
por: Li, De-feng, et al.
Publicado: (2023)

Customizing delivery nano-vehicles for precise brain tumor therapy
por: Miao, Yang-Bao, et al.
Publicado: (2023)

Exosomes and cancer - Diagnostic and prognostic biomarkers and therapeutic vehicle
por: Wang, Xia, et al.
Publicado: (2022)

Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases
por: Guo, Jiawei, et al.
Publicado: (2023)

The Potential of Natural Oils to Improve Inflammatory Bowel Disease
por: Zhou, Yaxi, et al.
Publicado: (2023)

Exosomes, a New Star for Targeted Delivery
por: Chen, Huizhi, et al.
Publicado: (2021)

Development of a pH-Responsive Particulate Drug Delivery Vehicle for Localized Biologic Therapy in Inflammatory Bowel Disease
por: Capurso, Noah A., et al.
Publicado: (2011)

Mesenchymal stem cells-derived exosomes for drug delivery
por: Sun, Yao, et al.
Publicado: (2021)

Vehicles of intercellular communication: exosomes and HIV-1
por: Welch, Jennifer L., et al.
Publicado: (2019)

Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges
por: Ha, Dinh, et al.
Publicado: (2016)

Advances in Mesenchymal Stem Cell-Derived Exosomes as Drug Delivery Vehicles
por: Rao, Dingyu, et al.
Publicado: (2022)

Embryonic Stem Cells‐Derived Exosomes Endowed with Targeting Properties as Chemotherapeutics Delivery Vehicles for Glioblastoma Therapy
por: Zhu, Qingwei, et al.
Publicado: (2019)

Exosomes‐transferred LINC00668 Contributes to Thrombosis by Promoting NETs Formation in Inflammatory Bowel Disease
por: Zhang, Long, et al.
Publicado: (2023)

New Trends in Inflammatory Bowel Disease
por: Palmela, Carolina, et al.
Publicado: (2015)

Inflammatory Bowel Disease and Neurodegenerative Diseases
por: Kim, Jin Sun, et al.
Publicado: (2023)

Oral Nanomedicines for siRNA Delivery to Treat Inflammatory Bowel Disease
por: Shinn, Jongyoon, et al.
Publicado: (2022)

New treatment options for inflammatory bowel diseases
por: Verstockt, Bram, et al.
Publicado: (2018)

Advancing the precision management of inflammatory bowel disease in the era of omics approaches and new technology
por: Liu, Xin-Yu, et al.
Publicado: (2023)

Serum exosomal pregnancy zone protein as a promising biomarker in inflammatory bowel disease
por: Shao, Jing, et al.
Publicado: (2021)

Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: Opportunities and emerging strategies
por: Liu, Peng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_66q3k6ojnkq9k9c10e5t0er5qf